(META) Meta Platforms - Overview
Sector: Communication Services | Industry: Internet Content & Information | Exchange: NASDAQ (USA) | Market Cap: 1.541.788m USD | Total Return: -4.7% in 12m
Avg Turnover: 8.34B
EPS Trend: 94.7%
Qual. Beats: 11
Rev. Trend: 99.9%
Qual. Beats: 4
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Meta Platforms, Inc. operates as a global technology conglomerate focused on social networking, artificial intelligence, and immersive hardware. The company is structured into two primary segments: Family of Apps (FoA), which encompasses Facebook, Instagram, Messenger, WhatsApp, and Threads; and Reality Labs (RL), which develops virtual reality (VR) headsets, augmented reality (AR) glasses, and neural interface technology. Meta generates the vast majority of its revenue through digital advertising, leveraging its massive user base to provide targeted marketing solutions for businesses.
The company operates within the Interactive Media & Services sub-industry, where platform monetization is driven by user engagement and data-driven ad placement. Meta has pivoted significantly toward artificial intelligence and the metaverse, investing in proprietary hardware like the Quest series and Ray-Ban Meta glasses to establish a computing platform beyond mobile devices. Strategic collaborations with semiconductor and software leaders like NVIDIA and Microsoft support its AI infrastructure and large language model development.
Investors should examine ValueRay for further data on Meta’s long-term valuation trends.
- Ad revenue growth driven by AI-powered Reels monetization and targeting
- Reality Labs operating losses impact overall margin and capital allocation
- Global regulatory scrutiny on data privacy and antitrust poses compliance risks
- Scaling Meta AI across Family of Apps increases user engagement and retention
- Capital expenditure on data centers and custom silicon increases infrastructure costs
| Net Income: 70.6b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -6.46 > 1.0 |
| NWC/Revenue: 29.31% < 20% (prev 33.07%; Δ -3.76% < -1%) |
| CFO/TA 0.31 > 3% & CFO 124b > Net Income 70.6b |
| Net Debt (33.6b) to EBITDA (113b): 0.30 < 3 |
| Current Ratio: 2.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.56b) vs 12m ago -1.00% < -2% |
| Gross Margin: 81.94% > 18% (prev 0.82%; Δ 8.11k% > 0.5%) |
| Asset Turnover: 63.65% > 50% (prev 60.80%; Δ 2.85% > 0%) |
| Interest Coverage Ratio: 53.35 > 6 (EBITDA TTM 113b / Interest Expense TTM 1.74b) |
| A: 0.16 (Total Current Assets 110b - Total Current Liabilities 46.8b) / Total Assets 395b |
| B: 0.37 (Retained Earnings 145b / Total Assets 395b) |
| C: 0.27 (EBIT TTM 92.7b / Avg Total Assets 338b) |
| D: 1.61 (Book Value of Equity 244b / Total Liabilities 152b) |
| Altman-Z'' = 5.77 = AAA |
| DSRI: 0.95 (Receivables 17.5b/14.5b, Revenue 215b/170b) |
| GMI: 1.00 (GM 81.94% / 81.75%) |
| AQI: 1.17 (AQ_t 0.17 / AQ_t-1 0.15) |
| SGI: 1.26 (Revenue 215b / 170b) |
| TATA: -0.14 (NI 70.6b - CFO 124b) / TA 395b) |
| Beneish M = -2.92 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 610.26 with a total of 11,103,030 shares traded.
Over the past week, the price has changed by -0.65%,
over one month by -9.60%,
over three months by -4.46% and
over the past year by -4.69%.
Meta Platforms has received a consensus analysts rating of 4.54. Therefore, it is recommended to buy META.
- StrongBuy: 47
- Buy: 13
- Hold: 6
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 826.7 | 35.5% |
P/E Trailing = 22.0785
P/E Forward = 19.2308
P/S = 7.1449
P/B = 6.3029
P/EG = 0.8742
Revenue TTM = 215b USD
EBIT TTM = 92.7b USD
EBITDA TTM = 113b USD
Long Term Debt = 58.7b USD (from longTermDebt, last quarter)
Short Term Debt = 2.41b USD (from shortTermDebt, last quarter)
Debt = 115b USD (from shortLongTermDebtTotal, last quarter) + Leases 28.0b
Net Debt = 33.6b USD (calculated: Debt 115b - CCE 81.2b)
Enterprise Value = 1575b USD (1542b + Debt 115b - CCE 81.2b)
Interest Coverage Ratio = 53.35 (Ebit TTM 92.7b / Interest Expense TTM 1.74b)
EV/FCF = 32.65x (Enterprise Value 1575b / FCF TTM 48.3b)
FCF Yield = 3.06% (FCF TTM 48.3b / Enterprise Value 1575b)
FCF Margin = 22.45% (FCF TTM 48.3b / Revenue TTM 215b)
Net Margin = 32.84% (Net Income TTM 70.6b / Revenue TTM 215b)
Gross Margin = 81.94% ((Revenue TTM 215b - Cost of Revenue TTM 38.8b) / Revenue TTM)
Gross Margin QoQ = 81.85% (prev 81.79%)
Tobins Q-Ratio = 3.99 (Enterprise Value 1575b / Total Assets 395b)
Interest Expense / Debt = 1.51% (Interest Expense 1.74b / Debt 115b)
Taxrate = 29.64% (25.5b / 85.9b)
NOPAT = 65.2b (EBIT 92.7b * (1 - 29.64%))
Current Ratio = 2.35 (Total Current Assets 110b / Total Current Liabilities 46.8b)
Debt / Equity = 0.47 (Debt 115b / totalStockholderEquity, last quarter 244b)
Debt / EBITDA = 0.30 (Net Debt 33.6b / EBITDA 113b)
Debt / FCF = 0.70 (Net Debt 33.6b / FCF TTM 48.3b)
Total Stockholder Equity = 213b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.90% (Net Income 70.6b / Total Assets 395b)
RoE = 33.22% (Net Income TTM 70.6b / Total Stockholder Equity 213b)
RoCE = 34.18% (EBIT 92.7b / Capital Employed (Equity 213b + L.T.Debt 58.7b))
RoIC = 18.80% (NOPAT 65.2b / Invested Capital 347b)
WACC = 9.70% (E(1542b)/V(1657b) * Re(10.34%) + D(115b)/V(1657b) * Rd(1.51%) * (1-Tc(0.30)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.78 | Cagr: -1.12%
[DCF] Terminal Value 69.59% ; FCFF base≈49.9b ; Y1≈46.8b ; Y5≈43.4b
[DCF] Fair Price = 239.0 (EV 559b - Net Debt 33.6b = Equity 525b / Shares 2.20b; r=9.70% [WACC]; 5y FCF grow -7.76% → 2.50% )
EPS Correlation: 94.66 | EPS CAGR: 53.22% | SUE: 1.22 | # QB: 11
Revenue Correlation: 99.85 | Revenue CAGR: 22.38% | SUE: 0.94 | # QB: 4
EPS current Quarter (2026-06-30): EPS=7.20 | Chg30d=+1.10% | Revisions=+23% | Analysts=46
EPS next Quarter (2026-09-30): EPS=7.04 | Chg30d=-1.06% | Revisions=-33% | Analysts=44
EPS current Year (2026-12-31): EPS=32.85 | Chg30d=+11.04% | Revisions=+84% | GrowthEPS=+39.8% | GrowthRev=+25.9%
EPS next Year (2027-12-31): EPS=34.73 | Chg30d=+1.11% | Revisions=+15% | GrowthEPS=+5.7% | GrowthRev=+19.2%
[Analyst] Revisions Ratio: +84%